Source: Annual Congress 2006 - Epidemiology, clinical features, malignant pleural diseases, treatment
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Kirbas, A. Abakay, A. Senyigit, O. Abakay (Diyarbakir, Turkey). Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma. Eur Respir J 2006; 28: Suppl. 50, 4492

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Prognostic characteristics of malignant pleural mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Clinical and morphological prognostic factors in patients with malignant pleura mesothelioma (MPM) Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2003; 22: Suppl. 45, 62s Year: 2003 Prognostic factors in diffuse malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines Year: 2009 The analysis of clinicopathological characteristics and prognosis of malignant pleural mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Diagnostic and prognostic significance of survivin levels in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Therapeutic outcome and prognostic factors in patients with pleural mesothelioma Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005 Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011 Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Diagnostic utility of biochemical parameters in patients with pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001 Prognostic value of metabolic imaging in non small cell lung cancers with neoplasic pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 206s Year: 2007 Clinical and laboratorial variables useful in the differential diagnosis of pleural effusions secondary to tuberculosis or lymphoma Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011